SIP
VMD icon

Stoneridge Investment Partners’s Viemed Healthcare VMD Stock Holding History

Stoneridge Investment Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,061
Closed -$111K – 194
2026
Q1 		$111K Sell
12,061
-5,451
-31% -$45.4K 0.08% 113
2025
Q4 		$130K Buy
17,512
+4,150
+31% +$28.4K 0.09% 112
2025
Q3 		$91K Buy
13,362
+1,200
+10% +$8.12K 0.06% 113
2025
Q2 		$84K Sell
12,162
-1,958
-14% -$13.3K 0.06% 109
2025
Q1 		$103K Hold
14,120
– – 0.09% 94
2024
Q4 		$113K Buy
14,120
+2,559
+22% +$22.2K 0.04% 116
2024
Q3 		$85K Hold
11,561
– – 0.03% 107
2024
Q2 		$76K Buy
+11,561
New +$87.1K 0.03% 118

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Stoneridge Investment Partners's VMD Position: Q2 2026 in Review

Stoneridge Investment Partners sold out of Viemed Healthcare (VMD) in Q2 2026, closing a stake of 12,061 shares — an estimated $111K sold.

Stoneridge Investment Partners first reported a position in VMD in Q2 2024 and held it in 8 quarters. The position peaked at $130K in Q4 2025. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Stoneridge Investment Partners reported no remaining Viemed Healthcare position as of Q2 2026 after selling out during the quarter.
  • Stoneridge Investment Partners sold 12,061 Viemed Healthcare shares in Q2 2026, an estimated $111K.
  • Stoneridge Investment Partners first reported a position in Viemed Healthcare in Q2 2024 and held it in 8 quarters.
  • Stoneridge Investment Partners's Viemed Healthcare position peaked at $130K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.